ahlam1399
06-06-2015, 10:27 PM
Lilly insulin tops Sa**fi?s Lantus in trials; liver issue persists
June 6 (Reuters) - A long-acting insulin being developed by Eli Lilly and Co demonstrated greater blood sugar reduction than Sa**fi SA's top-selling Lantus in patients with type 2 diabetes, according to data from three Phase III trials presented on Saturday.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46ffb603/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/ach.img (http://adchoice.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/ach.htm)http://pi.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2t.imghttp://pi2.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=NnZj79l9txo:mQz4u_7Hx2c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=NnZj79l9txo:mQz4u_7Hx2c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/NnZj79l9txo
June 6 (Reuters) - A long-acting insulin being developed by Eli Lilly and Co demonstrated greater blood sugar reduction than Sa**fi SA's top-selling Lantus in patients with type 2 diabetes, according to data from three Phase III trials presented on Saturday.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46ffb603/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2.img (http://da.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/ach.img (http://adchoice.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/ach.htm)http://pi.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2t.imghttp://pi2.feedsportal.com/r/231041443810/u/49/f/654213/c/35217/s/46ffb603/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=NnZj79l9txo:mQz4u_7Hx2c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=NnZj79l9txo:mQz4u_7Hx2c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=NnZj79l9txo:mQz4u_7Hx2c:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/NnZj79l9txo